FIELD OF THE INVENTION
The present invention relates generally to certain benzofuran cannabinoid compounds. The compounds are useful for the treatment of cannabinoid receptor-mediated condition, such as, for example, cancer and the like. The present invention also relates to pharmaceutical
BACKGROUND
CB1 and CB2 are two cannabinoid receptors that belong to the GPCR family and have very different functions and distribution. While no x-ray structure is available for these receptors, various models have been described on the basis of the x-ray structure of rhodopsin, a GPCR belonging